The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd

L Peintner1, L Dorstyn2, S Kumar2

  • 1Division of Developmental Immunology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Insights

Receptor-interacting protein-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD) does not influence c-Myc-driven lymphomagenesis or DNA-damage-induced cancer. RAIDD

Area of Science:

  • Molecular biology
  • Cell death regulation
  • Cancer research

Background:

  • Receptor-interacting protein-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD) is a dual adaptor protein involved in inflammation and cell death.
  • RAIDD is a component of the PIDDosome complex, linking Caspase-2 and PIDD1, and has been implicated in apoptosis and tumorigenesis.
  • Caspase-2 acts as a tumor suppressor, while PIDD1 acts as a tumor promoter in the Emicro-Myc mouse lymphoma model.

Purpose of the Study:

  • To investigate the role of RAIDD in cancer, particularly in relation to Caspase-2 and PIDD1 functions.
  • To determine if RAIDD deficiency modulates lymphomagenesis or DNA-damage-induced cancer in mice.

Main Methods:

  • Analysis of Emicro-Myc/Raidd(-/-) mice to assess lymphomagenesis.
  • Evaluation of Raidd deficiency's effect on DNA-damage-driven cancer models.

Main Results:

  • Raidd deficiency did not protect against c-Myc-driven lymphomagenesis in Emicro-Myc/Raidd(-/-) mice.
  • Loss of Raidd did not significantly affect the onset or progression of DNA-damage-induced cancer.
  • The tumor suppressor role of Caspase-2 and the tumor promoter role of PIDD1 are independent of their interaction with the RAIDD scaffold.

Conclusions:

  • RAIDD does not play a significant role in modulating Caspase-2 or PIDD1 functions in the context of c-Myc-driven lymphomagenesis or DNA-damage-induced cancer.
  • Alternative signaling pathways likely mediate the tumor suppressor function of Caspase-2 and the tumor promoter function of PIDD1.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K